123 related articles for article (PubMed ID: 6791937)
1. Clofibrate treatment and bile cholesterol saturation: short-term and long-term effects and influence of combination with chenodeoxycholic acid.
Angelin B; Einarsson K; Leijd B
Eur J Clin Invest; 1981 Jun; 11(3):185-9. PubMed ID: 6791937
[TBL] [Abstract][Full Text] [Related]
2. Effect of ciprofibrate treatment on biliary lipids in patients with hyperlipoproteinaemia.
Angelin B; Einarsson K; Leijd B
Eur J Clin Invest; 1984 Feb; 14(1):73-8. PubMed ID: 6421601
[TBL] [Abstract][Full Text] [Related]
3. Biliary lipid composition during treatment with different hypolipidaemic drugs.
Angelin B; Einarsson K; Leijd B
Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
[TBL] [Abstract][Full Text] [Related]
4. Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid.
Bateson MC; Ross PE; Murison J; Bouchier IA
Br Med J; 1978 May; 1(6121):1171-3. PubMed ID: 638677
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics.
Angelin B; Nilsell K; Einarsson K
Eur J Clin Invest; 1986 Apr; 16(2):169-77. PubMed ID: 3089812
[TBL] [Abstract][Full Text] [Related]
6. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
Kutz K; Schulte A
Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
[TBL] [Abstract][Full Text] [Related]
7. Effect of chenodeoxycholic acid on serum and biliary lipids in patients with hyperlipoproteinaemia.
Angelin B; Einarsson K; Leijd B
Clin Sci Mol Med; 1978 Apr; 54(4):451-5. PubMed ID: 639478
[TBL] [Abstract][Full Text] [Related]
8. Bezafibrate therapy and biliary lipids: effects of short-term and long-term treatment in patients with various forms of hyperlipoproteinaemia.
Eriksson M; Angelin B
Eur J Clin Invest; 1987 Oct; 17(5):396-401. PubMed ID: 3121342
[TBL] [Abstract][Full Text] [Related]
9. Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.
Mazzella G; Bazzoli F; Villanova N; Simoni P; Festi D; Roda A; Aldini R; Roda E
Scand J Gastroenterol; 1990 Dec; 25(12):1227-34. PubMed ID: 2274744
[TBL] [Abstract][Full Text] [Related]
10. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Grundy SM; Mok HY
J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
[TBL] [Abstract][Full Text] [Related]
12. [Chenodeoxycholic acid. Indications in biliary pathology and hyperlipoproteinemias].
Chevrel B
Med Chir Dig; 1980; 9(1):31-4. PubMed ID: 7392696
[No Abstract] [Full Text] [Related]
13. Gemfibrozil--the effect of biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate.
Hall MJ; Nelson LM; Russell RI; Howard AN
Atherosclerosis; 1981 Jul; 39(4):511-6. PubMed ID: 6942844
[TBL] [Abstract][Full Text] [Related]
14. Effect of short-term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipoproteinaemia.
von Bergmann K; Leiss O
Eur J Clin Invest; 1984 Apr; 14(2):150-4. PubMed ID: 6428905
[TBL] [Abstract][Full Text] [Related]
15. [Changes in bile and blood lipid levels following chenodeoxycholic acid therapy].
Barbara L; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Sorci F; Roda E
Minerva Med; 1977 Sep; 68(43):3023-6. PubMed ID: 909650
[TBL] [Abstract][Full Text] [Related]
16. Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.
Bateson MC; Maclean D; Evans JR; Bouchier IA
Br J Clin Pharmacol; 1978 Mar; 5(3):249-54. PubMed ID: 656270
[TBL] [Abstract][Full Text] [Related]
17. The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
Lithell H; Vessby B; Boberg J; Hellsing K
Atherosclerosis; 1980 Oct; 37(2):175-86. PubMed ID: 7000089
[TBL] [Abstract][Full Text] [Related]
18. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
Iser JH; Murphy GM; Dowling RH
Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
[TBL] [Abstract][Full Text] [Related]
19. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM
Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091
[TBL] [Abstract][Full Text] [Related]
20. Serum lipoprotein lipids after gemfibrozil treatment.
Schwandt P; Weisweiler P; Neureuther G
Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
